Summary
The key event associated with the initiation of angiogenesis is the localized degradation of the vascular basement membrane. Because of its complex structure, any remodelling and/or modification of the basement membrane must involve the co-ordinated function of a number of different enzyme systems. Type IV collagen is a major protein component (60–90%) of the basement membrane and its degradation is crucial to the initiation of angiogenesis. This study has focused on the mechanisms by which C6 astrocytoma cells degrade human type IV collagen. C6 astrocytoma cells use components of two major degradative pathways to degrade collagen type IV. The major matrix metalloproteinase identified is the activated form (68-KDa) of gelatinase A (72-KDa matrix metalloproteinase) and a serine sensitive 1000-KDa collagenase type IV degrading activity which appears to have the characteristics of a novel extracellular proteasome.
Similar content being viewed by others
References
Del Maestro RF, Megyesi JF, Farrell CL: Mechanisms of tumor-associated edema: A review. Canadian Journal of Neurological Sciences 17: 177–183, 1990
Stewart PA, Hayakawa K, Farrell CL: Quantitative study of microvessel ultrastructure in human peritumoral brain tissue. Journal of Neurosurgery 67: 697–705, 1987
Blood CH, Zetter BR: Tumor interactions with the vasculature: Angiogenesis and tumor metastasis. Biochemica Bio-physica Acta 1032: 89–118, 1990
Brem S, Cotran R, Folkman J: Tumor angiogenesis: A quantitative method for histological grading. Journal National Cancer Institute 48: 347–356, 1972
Folkman J: Angiogenesis: Initiation and modulation. In: Nicolson GL, Milas L (eds) Cancer Invasion and Metastasis: Biologic and Therapeutic Aspects. Raven Press, New York, 1984, pp 201–208
Folkman J: How is blood vessel growth regulated in normal and neoplastic tissues? Clowes Memorial Award Lecture. Cancer Research 6: 467–473, 1986
Stanley JR, Woodley DT, Katz SI, Martin GR: Structure and function of basement membrane. Journal of Investigational Dermatology 79: 69–72, 1982
Timpl R: Review structure and biological activity of basement membrane proteins. European Journal of Biochemistry 180: 487–502, 1989
Vaithilingam IS, McDonald W, Brown NK, Stroude EC, Cook RA, Del Maestro RF: Serum proteolytic activity during the growth of C6 astrocytoma. Journal of Neurosurgery 77: 595–600, 1992
Klagsbrun M: The affinity of fibroblast growth factors (FGFs) for heparin, FGF-heparin sulfate interactions in cells and extracellular matrix. Current Opinion Cell Biology 2: 857–863, 1990
Birkedal-Hansen H, Moore WGE, Bodden MK, Windsor LJ, Birdedal-Hansen B, DeCarlo A, Engler JA: Matrix metalloproteinases: A review. Critical Reviews in Oral Biology and Medicine 4(2): 197–250, 1993
DeClerck YA, Shimada H, Gonzalez-Gomez I, Raffel C: Tumoral invasion in the central nervous system. Journal of Neuro-Oncology 18: 111–121, 1994
Thorgeirsson UP, Lindsay CK, Cottam DW, Gomez DE: Tumor invasion, proteolysis and angiogenesis. Journal of Neuro-Oncology 18: 89–103, 1994
Woessner Jr. JF: Matrix metalloproteinases and their inhibitors in connective tissue remodelling. FASEB Journal 5: 1991, 1991
Vaithilingam IS, Stroude EC, McDonald W, Del Maestro RF: General protease and collagenase IV activity in C6 astrocytoma cells, C6 spheroids and implanted C6 spheroids. Journal of Neuro-Oncology 10: 203–212, 1991
Vaithilingam IS, McDonald W, Stroude EC, Cook RA, Del Maestro RF: Proteolytic activity during the growth of C6 astrocytoma in the murine spheroid implantation model. Canadian Journal of Neurological Sciences 19: 17–22, 1992
Vailthilingam IS, McDonald W, Malott DW, DelMaestro RF: An extracellular proteasome-like structure from C6 astrocytoma cells with serine collagenase IV activity and metallo-dependent activity on α-casein and β-insulin. J Biol Chem 270: 4588–4593, 1995
Weiss JB, Brown RA, Kumar S, Phillips P: An angiogenic factor isolated from tumors: A potent low-molecular weight compound. British Journal of Cancer 40: 493–496, 1979
McLaughlin B, Cawston T, Weiss JB: Activation of the matrix metalloproteinase inhibitor complex by low molecular weight angiogenic factor. Biochimica Biophysica Acta 1073: 295–298, 1991
Taylor CM, Weiss JB, Lye RH: Raised levels of latent collagenase activating angiogenesis factor (ESAF) are present in actively growing human intracranial tumors. British Journal of Cancer 64: 164–168, 1991
Del Maestro RF, Vaithilingam IS, McDonald W, Weiss JB: Elevated levels of a collagenase IV activating factor in C6 astrocytoma cells. Journal of Cell Biochemistry (Suppl) 18D: 142, 1994
Sato H, Takino T, Okada Y, Kao J, Shinagawa A, Yamamoto E, Seiki M: A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370: 61–65, 1994
Rivett AJ: The multicatalytic proteinase. Multiple proteo-lytic activities. Journal of Biological Chemistry 264: 12215–12219, 1989
Orlowski M: The multicatalytic proteinase complex, a major extralysosomal proteolytic system. Biochemistry 29: 10289–10297, 1990
Goldberg AL, Rock KL: Proteolysis, proteasomes and antigen presentation. Nature 357: 375–379, 1992
Tanaka K, Ichihara A: Proteasomes (multicatalytic proteinase complexes) in eukaryotic cells. Cell Structure and Function 15: 127–132, 1990
Tanaka K, Tamura T, Yoshimura T, Ichihara A: Proteasomes: Protein and gene structures. The New Biologist 4: 173–187, 1992
Gray CW, Slaughter CA, DeMartino GN: PA28 activator protein forms regulatory caps on proteasome stacked rings. Journal of Molecular Biology 236: 7–15, 1994
Kumatori A, Tanaka K, Inamura N, Sone S, Ogura T, Matsumoto T, Tachikawa T, Shin S, Ichihara A: Abnormally high expression of proteasomes in human leukemic cells. Proceedings of National Academy of Science USA 87: 7071–7078, 1990
Kanayama H, Tanaka K, Aki M, Kagawa S, Miyaji H, Satoh M, Okada F, Sato S, Shimbara N, Ichihara A: Changes in expressions of proteasomes and ubiquitin genes in human renal cancer cells. Cancer Research 51: 6677–6685, 1991
Wada M, Kosaka M, Saito S, Sano T, Tanaka K, Ichihara A: Serum concentration and localization in tumor cells of proteasomes in patients with hematologic malignancy and their pathophysiologic significance. Journal of Laboratory and Clinical Medicine 121: 215–223, 1993
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Del Maestro, R.F., Vaithilingam, I.S. & McDonald, W. Degradation of collagen type IV by C6 astrocytoma cells. J Neuro-Oncol 24, 75–81 (1995). https://doi.org/10.1007/BF01052662
Issue Date:
DOI: https://doi.org/10.1007/BF01052662